Keryx Biopharma (KERX) Posts Q4 Loss of 44c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
February 25, 2015 4:10 PM ESTNEW YORK, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that corporate presentations will be delivered at the following upcoming investor conferences:
Cowen and Company 35th Annual Health Care Conference (Boston, MA) Presenter: Greg Madison, President and Chief Operating Officer... More
